Results 101 to 110 of about 5,138,843 (349)

On the change of information technology in the field of Medical Biometry and Statistics

open access: yesGMS Medizinische Informatik, Biometrie und Epidemiologie, 2005
An overview on the applications of information technology (IT) in Medical Biometry and Statistics is given using the developments at the Department of Medical Biometry and Statistics in Freiburg for illustration.
Roßner, Reinhard
doaj  

Access, Fall 2010 [PDF]

open access: yes, 2010
https://scholarworks.sjsu.edu/accessmagazine/1000/thumbnail ...
San Jose State University, School of Journalism and Mass Communications
core   +1 more source

An Early Medical Illustration of Paroxysmal Dystonic Phenomena. [PDF]

open access: yesMov Disord Clin Pract, 2022
Brigo F   +2 more
europepmc   +1 more source

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

open access: yesMolecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad   +17 more
wiley   +1 more source

A Monte-Carlo planning strategy for medical follow-up optimization: Illustration on multiple myeloma data.

open access: yesPLoS ONE
Designing patient-specific follow-up strategies is key to personalized cancer care. Tools to assist doctors in treatment decisions and scheduling follow-ups based on patient preferences and medical data would be highly beneficial.
Benoîte de Saporta   +3 more
doaj   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

Is dermatological lilac really lilac?

open access: yesDermatologica Sinica, 2018
Background/Objective: Dermatologists use the word lilac to describe a shade of erythema; especially in lichen planus, morphea, and dermatomyositis. The aim of this study to determine whether or not there is a color really consistent with a lilac color ...
Bilge Fettahlıoğlu Karaman   +3 more
doaj   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

open access: yesMolecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard   +12 more
wiley   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

open access: yesMolecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy